Stock ACXP ACURX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Acurx Pharmaceuticals, Inc.

Equities

ACXP

US00510M1045

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/06/2024 BST 		5-day change 1st Jan Change
2.33 USD +4.48% Intraday chart for Acurx Pharmaceuticals, Inc. -4.12% -39.16%
05-15 Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection CI
05-15 Transcript : Acurx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 15, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ACURX PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
+4.48%-4.12%-39.16%-14.34% - 35.33M
Neutral
Bearish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ACXP Stock
  4. Charts Acurx Pharmaceuticals, Inc.
  5. Comparison Chart